At a Glance
- Tasks: Monitor clinical sites and build strong investigator relationships while ensuring patient safety.
- Company: Novotech, a leader in clinical development with a supportive and collaborative culture.
- Benefits: Flexible hybrid working, leadership support, and focus on professional growth.
- Other info: Opportunity for career advancement in a fast-paced environment.
- Why this job: Join a dynamic team making a real difference in clinical research and patient care.
- Qualifications: Experience as a CRA II or III with strong monitoring skills.
The predicted salary is between 85500 - 104500 $ per year.
Novotech is seeking experienced CRAs (CRA II/CRA III) in Australia to monitor sites across Early Clinical Development and Phase I-III.
The role emphasizes flexible, hybrid working, leadership support, and a collaborative culture focused on high-quality data and patient safety.
You will independently monitor sites, build strong investigator relationships, and drive patient recruitment while leveraging IHCRA and Regulatory Start-Up support.
Hybrid CRA II-III in Melbourne — Flexible Growth employer: Novotech
Novotech is an exceptional employer that fosters a dynamic and collaborative work culture, perfect for those passionate about advancing their careers in toxicology and regulatory affairs. Located in Australia, we offer our employees comprehensive growth opportunities, competitive benefits, and the chance to work alongside industry experts on cutting-edge projects in clinical trials. Join us to make a meaningful impact in the field while enjoying a supportive environment that values innovation and professional development.
